Clinical Trial Update: Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing levofloxacin and moxifloxacin in multidrug-resistant tuberculosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• Levofloxacin (Levofloxacin)
• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: TB | Phase 3 | Status: TERMINATED